Individual #00417629

ID_report older twin
Reference PubMed: Kim 2013
Remarks identical twin 1
Gender F
Consanguinity -
Country -
Population -
Age at death -
VIP -
Data_av -
Treatment B6 (pyridoxine) 300 mg daily and an arginine-restricted diet
Panel size 1
Diseases GACR
Owner name LOVD
Database submission license Creative Commons Attribution 4.0 InternationalCreative Commons License
Created by Anna Tracewska
Date created 2022-09-20 20:26:57 +02:00 (CEST)
Date last edited N/A


Phenotypes

atrophy, gyrate, of choroid and retina (GACR; ornithine aminotransferase deficiency (OATD)) (GACR;OATD)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000309096 older twin best-corrected visual acuity: 20 / 32 both eyes; refractive error right/left eye: -17.75 / -17.25 diopter; bilateral posterior subcapsular cataracts; fundus: bilateral severe chorioretinal atrophy involving the midperiphery; fluorescein angiography: leakage at the margin of chorioretinal atrophy and dye accumulation in the maculae of both eyes; cystoid macular edema evident in both eyes on optical coherence tomography; dynamic Goldmann perimetry: visual field constriction in both eyes; full-field electroretinogram: markedly impaired photopic and scotopic responses; amino acid analysis: markedly elevated plasma levels of ornithine (783 umol/l; normal range, 48 to 195 umol/l); tandem mass spectrometry: plasma ornithine levels of 380 umol/l (cutoff, 290 umol/l) ; treated with vitamin B6 (pyridoxine) 300 mg daily and an arginine-restricted diet, after three months, plasma ornithine levels measured by tandem mass spectrometry: 254 umol/l; visual acuity in each eye were preserved with no progression of chorioretinal atrophy on fundoscopy after 15 months, plasma ornithine levels: 386 umol/l - atrophy, gyrate, of choroid and retina (GACR; ornithine aminotransferase deficiency (OATD)) Familial, autosomal recessive 19y - - progressive night vision deterioration occurring over the past several years - LOVD



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000418925 DNA SEQ - - OAT 2 LOVD



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
10 Unknown +/. - pathogenic g.126097206C>T g.124408637C>T OAT c.425G>A - OAT_000042 heterozygous; segregation not performed PubMed: Kim 2013 - - Germline ? - - - - LOVD OAT - - - - - NM_000274.3:c.425G>A - r.(?) p.(Gly142Glu) - - - - - - - - - - - - - -
10 Unknown ?/. - VUS g.126100527_126100532dup g.124411958_124411963dup OAT c.199+11_199+16dupAATTAA - OAT_000099 heterozygous; segregation not performed PubMed: Kim 2013 - - Germline ? - - - - LOVD OAT - - - - - NM_000274.3:c.199+11_199+16dupAATTAA - r.spl? p.? - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.